
Brings real-world examples to learning.
A true mentor who cares about success.
Always patient and encouraging to students.
Brings enthusiasm to every interaction.
Helps students see the bigger picture.
Dr Reza Feizerfan serves as an Adjunct Clinical Senior Lecturer at Curtin University in Medicine, actively contributing to medical education and training in pain medicine and anaesthesia. A dual specialist in pain medicine and anaesthesia, he holds the qualifications MD, FRCA (obtained in 2013), FANZCA, and FFPMANZCA. He completed his specialist anaesthesia training in the United Kingdom between 2005 and 2015, while concurrently undertaking advanced pain medicine training through a combined fellowship traineeship at Royal Prince Alfred and Concord Repatriation Hospitals in Sydney.
In his clinical career, Dr Feizerfan founded Pain Specialists WA in 2019, delivering multidisciplinary pain management, independent medical examinations, and specialist second opinions from consulting rooms in Nedlands and Murdoch. He maintains appointments at Sir Charles Gairdner Hospital Pain Management Centre and Osborne Park Hospital, working within public multidisciplinary pain teams. He performs interventional pain procedures at private hospitals including Mount Private Hospital, St John of God Subiaco Hospital, St John of God Murdoch Hospital, St John of God Mt Lawley Hospital, Glengarry Private Hospital, and South Perth Hospital. His practice focuses on comprehensive acute and chronic pain services, pain management in seniors, regional nerve block techniques, and interventional methods, with telehealth available and no-gap provision for eligible patients. Dr Feizerfan also serves as Supervisor of Training at the SCGH Pain Management Centre. His interests encompass minimising acute to chronic pain transition and collaborative care. He has authored articles in Medical Forum magazine on interventional pain management for knee osteoarthritis (March 2024), chronic pain in the elderly (December 2024), pain techniques for cancer patients (February 2025), and geriatric chronic pain challenges.
